HIF1A and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, it was suggested that activation of glycolytic metabolism in CML cells may be facilitated by reduced expression of miR-18a-5p, which targets the 3’-UTR of HIF1α and leads to HIF1α downregulation in normal hematopoietic cells (107).